Gastric Cancer

Article	Citations
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)	373
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial	90
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors	82
Apatinib induced ferroptosis by lipid peroxidation in gastric cancer	79
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial	76
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab	66
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)	61
Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy	56
Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer	48
Artificial intelligence-based diagnosis of upper gastrointestinal subepithelial lesions on endoscopic ultrasonography images	43
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07	42
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models	38
Landscape of EBV-positive gastric cancer	37
Deep learning system for lymph node quantification and metastatic cancer identification from whole-slide pathology images	36
Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling	35
Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial	35
Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort	35
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer	34
Optimized PD-L1 scoring of gastric cancer	31
A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics	29
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer	29
Hospital volume following major surgery for gastric cancer determines in-hospital mortality rate and failure to rescue: a nation-wide study based on German billing data (2009–2017)	28
Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based	27
Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways	26
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance	26

CAF promotes chemoresistance through NRP2 in gastric cancer	25
Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study	25
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia	24
Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma	24
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma	24
Safe implementation of robotic gastrectomy for gastric cancer under the requirements for universal health insurance coverage: a retrospective cohort study using a nationwide registry database in Japan	23
Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy	23
Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis	23
Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer	23
Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective	23
Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry	22
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial	21
Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study	21
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis	21
Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14	21
EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway	20
Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis	20
Comparison between endoscopic submucosal resection and surgery for the curative resection of undifferentiated-type early gastric cancer within expanded indications: a nationwide multi-center study	20
Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma	20
Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type	19
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?	19
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer	19
A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)	19
Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry	19
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer	19
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma	19
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08)	19
A novel combination of serum microRNAs for the detection of early gastric cancer	19
WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers	19
Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast	19
Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit	18
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer	18
Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression	18
Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study	17
LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway	16
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab	16
Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations	16
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer	16
ADAMTS10 inhibits aggressiveness via JAK/STAT/c-MYC pathway and reprograms macrophage to create an anti-malignant microenvironment in gastric cancer	15
Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy	15
Robotic gastrectomy for gastric cancer: systematic review and future directions	15
Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells	15
LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway	15
SHARPIN stabilizes β-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis	15
Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells	15
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women	15
CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6	15
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial	14
Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histol	14
Insulin and the insulin receptor collaborate to promote human gastric cancer	14

The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration	14
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer	14
SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence	13
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials	13
Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China	13
Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression	13
Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation	12
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601	12
IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC	12
Clinical advantage of standardized robotic total gastrectomy for gastric cancer: a single-center retrospective cohort study using propensity-score matching analysis	12
The clinical impact of frailty on the postoperative outcomes of patients undergoing gastrectomy for gastric cancer: a propensity-score matched database study	12
Gastric equivalent of the ‘Holy Plane’ to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson’s historic schema	12
Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial	12
Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study	12
Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3)	12
Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world	12
Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)	12
miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer	12
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?	11
Adequate period of surveillance in each stage for curatively resected gastric cancer: analyzing the time and rates of recurrence	11
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study	11
Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning	11
The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer	11
Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis	11
Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study	11
Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients	11
Personalized therapeutic strategies in HER2-driven gastric cancer	11
Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE	11
Geographic impact on access to care and survival for non-curative esophagogastric cancer: a population-based study	10
Cooperation between artificial intelligence and endoscopists for diagnosing invasion depth of early gastric cancer	10
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy w	10
Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study	10
Neoadjuvant docetaxel, oxaliplatin and S‑1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction	10
International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study	10
CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma	10
Development and evaluation of a double-check support system using artificial intelligence in endoscopic screening for gastric cancer	10
Insertion–deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab	10
Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences	10
Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer	10
LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA	10
Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study	9
Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial	9
Brain metastases in gastroesophageal cancers—an underestimated complication	9
Improved survival after laparoscopic compared to open gastrectomy for advanced gastric cancer: a Swedish population-based cohort study	9
Quality of life after laparoscopic sentinel node navigation surgery in early gastric cancer: a single-center cohort study	9
International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk	9
Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy	9
Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis	9
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061	9
Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group s	9
The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa	9
Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance	9
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial	9
Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma	8
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry	8
IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment	8
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer	8
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)	8
Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients	8
Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response	8
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study	7
Gastric cancer exosomes contribute to the field cancerization of gastric epithelial cells surrounding gastric cancer	7
Prophylactic laparoscopic total gastrectomy for gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): the first report in Asia	7
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study	7
Survival analysis of a prospective multicenter observational study on surgical palliation among patients with malignant bowel obstruction caused by peritoneal dissemination of gastric cancer	7
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score	7
Dose–response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis	7
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer	7
Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells	7
Down-regulation of stimulator of interferon genes (STING) expression and CD8+ T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer	7
A deep-learning based system using multi-modal data for diagnosing gastric neoplasms in real-time (with video)	7
Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer	6
Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours	6
FAK/IL-8 axis promotes the proliferation and migration of gastric cancer cells	6
Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer	6
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma	6
Discrepancy between endoscopic and pathological ulcerative findings in clinical intramucosal early gastric cancer	6
Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric c	6
Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer	6
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model	6

Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials	6
Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice	6
Helicobacter pylori and gastric cancer: a lysosomal protease perspective	6
Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study	6
Deep learning for automatic diagnosis of gastric dysplasia using whole-slide histopathology images in endoscopic specimens	6
Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors	6
Survival trends in gastric cancer patients between 1987 and 2016: a population-based cohort study in Finland	6
Molecular profile of poorly cohesive gastric carcinoma with special reference to survival	6
Leukaemia inhibitory factor in gastric cancer: friend or foe?	6
Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6	5
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study	5
Synergistic effects of Rapamycin and Fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model	5
Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy	5
Development of a predictive model for extragastric recurrence after curative resection for early gastric cancer	5
Filling in the “GAPPS”: an unusual presentation of a child with gastric adenocarcinoma and proximal polyposis of the stomach	5
Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer	5
Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica	5
The potential role of nontyphoidal salmonellosis in gastric cancer: a nationwide matched cohort study	5
Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis	5
Collagen-related gene expression level predicts the prognosis and immune therapy response	5
Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection?	5
PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment	5
Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer	5
Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gast	5
Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome	5
Photodynamic therapy improves the outcome of immune checkpoint inhibitors via remodelling anti-tumour immunity in patients with gastric cancer	5
Reply to: Letter to editor on the article “Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy”	5
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmar	5
Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study	4
HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway	4
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study	4
Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses	4
Methylation silencing of ULK2 via epithelial–mesenchymal transition causes transformation to poorly differentiated gastric cancers	4
Clinical and endoscopic features of metachronous gastric cancer with possible lymph node metastasis after endoscopic submucosal dissection and Helicobacter pylori eradication	4
Circulating hormones and risk of gastric cancer by subsite in three cohort studies	4
Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands	4
Endoscopic differential diagnosis between foveolar-type gastric adenoma and gastric hyperplastic polyps in Helicobacter pylori-naïve patients	4
Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study	4
Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging	4
Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation	4
Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia	4
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study	4
SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis	4
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study	4
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plu	4
A comparative study of demarcation line diagnostic performance between non-magnifying observation with white light and non-magnifying observation with narrow-band light for early gastric cancer	4
Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer	4
A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401	4
Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains	4
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib	4
Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation	4
Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study	4
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)	4
Diagnosing and grading gastric atrophy and intestinal metaplasia using semi-supervised deep learning on pathological images: development and validation study	4
Recurrence of gastric cancer caused by implantation of tumor cells after curative endoscopic submucosal dissection	3
N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation	3
A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer	3
Correction to: Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation	3
FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes	3
Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer	3
Automatic surgical phase recognition-based skill assessment in laparoscopic distal gastrectomy using multicenter videos	3
Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma	3
Evaluation of the widths of the mucosal strips in pathological examination of specimens of endoscopic submucosal dissection for early gastric cancer	3
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer	3
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial	3
A rare gastric lesion: diminutive, well-differentiated, Grade 3, type 3 gastric neuroendocrine tumor with extremely high ki-67 index removed en bloc under endoscopy	3
rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori–infected individuals: a genome-wide association study in the Korean population	3
New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor	3
Incidence and risk factors of tuberculosis in patients following gastrectomy or endoscopic submucosal dissection: a cohort analysis of country-level data	3
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan	3
ATF4-mediated circTDRD3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-891b/ITGA2 axis and AKT signaling pathway	3
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action	3
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study	3
Feasibility and safety of inserting transient biodegradable stents in the pylorus during pylorus-preserving gastrectomy for gastric cancer: a preliminary study in a porcine for proof of concept	3
Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer	3
Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer	3
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort	3
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience	3
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma	3